Oct 10, 2019 7:00am EDT Can Fite Announces Publication of Namodenoson™ NASH Mechanism of Action in International Journal of Molecular Medicine
Sep 23, 2019 7:00am EDT Can-Fite Presents New Data on the Treatment of Advanced Liver Cancer with Namodenoson at the ILCA Conference
Sep 10, 2019 6:03am EDT Can-Fite Enters into Strategic Agreement with Univo Pharmaceuticals to Develop Cannabinoid-Based Pharmaceuticals and Assays
Sep 05, 2019 7:00am EDT Can-Fite to Present at H. C. Wainwright 21st Annual Global Investment Conference on September 10, 2019
Aug 29, 2019 7:00am EDT Can-Fite Reports Second Quarter 2019 Financial Results & Provides Clinical Update
Aug 06, 2019 7:00am EDT Can-Fite to Treat Advanced Liver Cancer Patients with Namodenoson Under Compassionate Use Setting in Israel
Aug 01, 2019 8:45am EDT Can-Fite Signs Agreement with Kyongbo Pharm for the Distribution in South Korea of Piclidenoson in the Treatment of Psoriasis
Jun 04, 2019 7:00am EDT Can-Fite Participating in One-on-One Partnering Meetings at the BIO International Convention on June 3-6, 2019
Jun 03, 2019 7:00am EDT Findings from Can-Fite’s Phase II Liver Cancer Study were Presented at ASCO Annual Meeting Late-Breaking Session
May 29, 2019 7:00am EDT Can-Fite Reports First Quarter 2019 Financial Results & Provides Clinical Update
